US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IN8bio, Inc.

2.16

0.0000

Volume:33.08K

Turnover:71.38K

Market Cap:7.44M

PE:-0.17

High:2.19

Open:2.16

Low:2.12

Close:2.16

Loading ...

Overview Company News Filings

Top Premarket Decliners

MT Newswires Live

IN8bio Inc trading halted, news pending

IN8bio Inc - Reverse Stock Split Effective June 5, 2025 - SEC Filing

THOMSON REUTERS

IN8BIO Inc. Announces 1-for-30 Reverse Stock Split Effective June 5, 2025

IN8BIO Inc. Publishes Presentation on Harnessing Gamma-Delta T Cell Therapies for Oncology and Autoimmune Diseases

IN8bio’s Promising Clinical Trial Results and Strategic Developments Justify Buy Rating

IN8BIO Inc. Unveils Presentation on Harnessing the Power of Gamma-Delta T Cells for Cancer Treatment

BRIEF-In8bio Presents Positive Phase 1 Data Of Inb-200 In Newly Diagnosed Gbm Demonstrating Prolonged Progression-Free Survival

IN8bio presents Phase 1 data on INB-200 in newly diagnosed GBM

IN8bio Inc - Inb-200 Is Well-Tolerated, Shows No Serious Toxicities Beyond Chemotherapy

THOMSON REUTERS

IN8bio Presents Positive Phase 1 Data of Inb-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival

THOMSON REUTERS

Mizuho Securities Sticks to Their Buy Rating for IN8bio (INAB)

IN8bio’s Strategic Growth and Development: Buy Rating Affirmed by Soumit Roy

Promising Developments and Financial Stability Support Buy Rating for IN8bio

IN8bio Q1 EPS $(0.07), Inline

IN8BIO Reports Q1 2025 Net Loss of $5.6M, EPS Improves to $0.07 Loss from $0.20, Cash Position at $11.9M

IN8bio Q1 Basic EPS USD -0.07

THOMSON REUTERS

IN8bio Q1 Net Income USD -5.55 Million

THOMSON REUTERS

Press Release: IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights

IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/INAB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":2.16,"timestamp":1751037235576,"preClose":2.16,"halted":0,"volume":33083,"delay":0,"floatShares":3009793,"shares":3444200,"eps":-13.03071,"marketStatus":"Trading","change":0,"latestTime":"06-27 11:20:01 EDT","open":2.16,"high":2.19,"low":2.12,"amount":71377.00588730001,"amplitude":0.032407,"askPrice":2.19,"askSize":700,"bidPrice":2.14,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-13.03071,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1751054400000},"marketStatusCode":2,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":2.16,"preHourTrading":{"tag":"盘前","latestPrice":2.16,"preClose":2.16,"latestTime":"09:28 EDT","volume":2625,"amount":5681.39775,"timestamp":1751030924856},"postHourTrading":{"tag":"盘后","latestPrice":2.2193,"preClose":2.16,"latestTime":"19:59 EDT","volume":2232,"amount":4941.0106,"timestamp":1750982397537},"volumeRatio":0.675916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","floatShares":3009793,"roa":"-73.25%","roe":"-174.66%","lyrEps":-17.05248,"volumeRatio":0.675916,"shares":3444200,"dividePrice":0,"high":2.19,"amplitude":0.032407,"preClose":2.16,"low":2.12,"week52Low":2.06,"pbRate":"0.54","week52High":27.6,"institutionHeld":0,"latestPrice":2.16,"committee":-0.75,"eps":-13.03071,"divideRate":0,"volume":33083,"delay":0,"ttmEps":-13.03071,"open":2.16,"prevYearClose":7.716,"prevWeekClose":2.18,"prevMonthClose":4.446,"prevQuarterClose":4.98,"fiveDayClose":2.18,"twentyDayClose":4.602,"sixtyDayClose":5.181},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INAB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542538441","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2542538441","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542538441?lang=en_us&edition=fundamental","pubTime":"2025-06-09 20:23","pubTimestamp":1749471800,"startTime":"0","endTime":"0","summary":"Sunnova Energy International  shares fell 28% in recent Monday premarket activity, after multiple media outlets reported that the company filed for Chapter 11 bankruptcy in Texas.The Children's Place  stock was down 27% after the company posted Friday a wider fiscal Q1 adjusted net loss and lower net sales from a year earlier.IN8bio  shares slid 12%, reversing from Friday's gain.Robinhood Markets  stock slipped more than 4% after Redburn Atlantic downgraded the company to sell from neutral, while raising its price target to $48 from $40.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4547","LU2249611893.SGD","LU2308191902.HKD","INAB","LU1861558580.USD","BK4127","LU2357125470.USD","LU2506951792.HKD","BK4539","NOVAQ","BK4094","LU1861559042.SGD","PLCE","LU0823414478.USD","BK4133","BK4585","LU0823414551.USD","NOVA","BK4139","LU2294711713.HKD"],"gpt_icon":1},{"id":"2541028750","title":"IN8bio Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2541028750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541028750?lang=en_us&edition=fundamental","pubTime":"2025-06-06 07:50","pubTimestamp":1749167413,"startTime":"0","endTime":"0","summary":"19:50 EDT IN8bio (INAB) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2540063427","title":"IN8bio Inc - Reverse Stock Split Effective June 5, 2025 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2540063427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540063427?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:03","pubTimestamp":1749038581,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S70F3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2540306321","title":"IN8BIO Inc. Announces 1-for-30 Reverse Stock Split Effective June 5, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540306321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540306321?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:00","pubTimestamp":1749038459,"startTime":"0","endTime":"0","summary":"IN8bio, Inc. announced a reverse stock split at a 1-for-30 ratio, effective June 5, 2025. As a result, every 30 shares of common stock will be consolidated into one share, with no change in the par value. Following this adjustment, approximately 3,444,234 shares will be outstanding. The company's stock will trade on a split-adjusted basis on Nasdaq starting June 6, 2025, under the new CUSIP number 45674E208. Fractional shares will not be issued, and cash payments will be made in lieu of them.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL1PzTsY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2540070755","title":"IN8BIO Inc. Publishes Presentation on Harnessing Gamma-Delta T Cell Therapies for Oncology and Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2540070755","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540070755?lang=en_us&edition=fundamental","pubTime":"2025-06-04 05:03","pubTimestamp":1748984604,"startTime":"0","endTime":"0","summary":"IN8bio Inc. has unveiled a corporate presentation highlighting their advancements in the development of gamma-delta (γδ) T cell therapies and T cell engagers  for oncology and autoimmune diseases. The company emphasizes the potential of γδ T cells, described as \"Nature's CAR-T\" cells, to directly kill cancer cells and orchestrate a broad immune response. IN8bio's T cell therapies aim to provide durable cancer remissions, with some patients experiencing over three years of progression-free survival. The presentation points out the precision and safety of γδ T cells, noting their lower rates of adverse events such as cytokine release syndrome and neurotoxicity. IN8bio's DeltExTM platform addresses key challenges in cell therapy and TCE development, while their γδ TCE construct is designed to efficiently deplete target cells and promote γδ T cell expansion. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL6J85rC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2540943757","title":"IN8bio’s Promising Clinical Trial Results and Strategic Developments Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2540943757","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540943757?lang=en_us&edition=fundamental","pubTime":"2025-06-02 23:25","pubTimestamp":1748877928,"startTime":"0","endTime":"0","summary":"IN8bio (INAB – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTrading ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/in8bios-promising-clinical-trial-results-and-strategic-developments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/in8bios-promising-clinical-trial-results-and-strategic-developments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB"],"gpt_icon":0},{"id":"2540795656","title":"IN8BIO Inc. Unveils Presentation on Harnessing the Power of Gamma-Delta T Cells for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795656","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540795656?lang=en_us&edition=fundamental","pubTime":"2025-06-02 21:33","pubTimestamp":1748871184,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. has released a presentation detailing its ongoing research and development efforts, with a focus on harnessing the power of Gamma-Delta T cells. The presentation highlights the progress and scope of clinical trials for its product candidates, including INB-100, INB-200, INB-400, and INB-600. IN8BIO is also exploring opportunities for certain programs and preclinical assets, supported by the potential to receive additional capital from convertible securities. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief on June 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL2RX1zs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2540760793","title":"BRIEF-In8bio Presents Positive Phase 1 Data Of Inb-200 In Newly Diagnosed Gbm Demonstrating Prolonged Progression-Free Survival","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760793","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760793?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:05","pubTimestamp":1748865920,"startTime":"0","endTime":"0","summary":"BRIEF-In8bio Presents Positive Phase 1 Data Of Inb-200 In Newly Diagnosed Gbm Demonstrating Prolonged Progression-Free SurvivalJune 2 (Reuters) - IN8bio Inc INAB.O:IN8BIO PRESENTS POSITIVE PHASE 1 DAT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S30AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2540760458","title":"IN8bio presents Phase 1 data on INB-200 in newly diagnosed GBM","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760458?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:50","pubTimestamp":1748865011,"startTime":"0","endTime":"0","summary":"IN8bio (INAB) announced new long-term clinical data from its fully enrolled Phase 1 trial of INB-200 in patients with newly diagnosed glioblastoma ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-presents-phase-1-data-on-inb-200-in-newly-diagnosed-gbm-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-presents-phase-1-data-on-inb-200-in-newly-diagnosed-gbm-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INB","BK4539","INAB"],"gpt_icon":0},{"id":"2540720767","title":"IN8bio Inc - Inb-200 Is Well-Tolerated, Shows No Serious Toxicities Beyond Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2540720767","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540720767?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:30","pubTimestamp":1748863819,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S30AY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2540703767","title":"IN8bio Presents Positive Phase 1 Data of Inb-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival","url":"https://stock-news.laohu8.com/highlight/detail?id=2540703767","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540703767?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:30","pubTimestamp":1748863819,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S30AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2534197168","title":"Mizuho Securities Sticks to Their Buy Rating for IN8bio (INAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534197168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534197168?lang=en_us&edition=fundamental","pubTime":"2025-05-09 02:56","pubTimestamp":1746730565,"startTime":"0","endTime":"0","summary":"In a report released today, Uy Ear from Mizuho Securities maintained a Buy rating on IN8bio (INAB – Research Report), with a price target of $2.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-in8bio-inab-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-in8bio-inab-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","INAB"],"gpt_icon":0},{"id":"2534415770","title":"IN8bio’s Strategic Growth and Development: Buy Rating Affirmed by Soumit Roy","url":"https://stock-news.laohu8.com/highlight/detail?id=2534415770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534415770?lang=en_us&edition=fundamental","pubTime":"2025-05-09 02:16","pubTimestamp":1746728167,"startTime":"0","endTime":"0","summary":"In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on IN8bio (INAB – Research Report), with a price target of $1.20. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/in8bios-strategic-growth-and-development-buy-rating-affirmed-by-soumit-roy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/in8bios-strategic-growth-and-development-buy-rating-affirmed-by-soumit-roy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB"],"gpt_icon":0},{"id":"2533590764","title":"Promising Developments and Financial Stability Support Buy Rating for IN8bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2533590764","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533590764?lang=en_us&edition=fundamental","pubTime":"2025-05-08 18:37","pubTimestamp":1746700660,"startTime":"0","endTime":"0","summary":"Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on IN8bio (INAB – Research Report) and keeping the price target at $6.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-and-financial-stability-support-buy-rating-for-in8bio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-and-financial-stability-support-buy-rating-for-in8bio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB"],"gpt_icon":0},{"id":"2533647339","title":"IN8bio Q1 EPS $(0.07), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2533647339","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533647339?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:46","pubTimestamp":1746650766,"startTime":"0","endTime":"0","summary":"IN8bio (NASDAQ:INAB) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 65 percent increase over losses of $(0.20) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45268420/in8bio-q1-eps-0-07-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2533966400","title":"IN8BIO Reports Q1 2025 Net Loss of $5.6M, EPS Improves to $0.07 Loss from $0.20, Cash Position at $11.9M","url":"https://stock-news.laohu8.com/highlight/detail?id=2533966400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533966400?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:03","pubTimestamp":1746648196,"startTime":"0","endTime":"0","summary":"IN8BIO Inc., a clinical-stage biopharmaceutical company, reported its financial results for the first quarter ending March 31, 2025. The company recorded a net loss of $5.6 million, or $0.07 per common share, an improvement from the net loss of $8.6 million, or $0.20 per share, in the same period the previous year. General and administrative expenses decreased to $2.7 million from $3.7 million, attributed to cost savings in personnel, insurance premiums, and professional services. The company's cash position was $11.9 million as of March 31, 2025, slightly down from $13.0 million in the previous year. In April 2025, IN8BIO raised additional gross proceeds of $1.9 million. On the operational front, IN8BIO continued to make strides in its gamma-delta T cell therapies. The Phase 1 clinical data for INB-100 showed promising long-term remission results in Acute Myeloid Leukemia patients, with all remaining relapse-free at a median follow-up of 20.1 months. The company also presented new dat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nNDL8dwpjn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2533965490","title":"IN8bio Q1 Basic EPS USD -0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2533965490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533965490?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:00","pubTimestamp":1746648000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nPLX82DFD3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2533496541","title":"IN8bio Q1 Net Income USD -5.55 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533496541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533496541?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:00","pubTimestamp":1746648000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nPLX82DFD3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2533896514","title":"Press Release: IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2533896514","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533896514?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:00","pubTimestamp":1746648000,"startTime":"0","endTime":"0","summary":"-- Phase 1 clinical data of INB-100 continues to demonstrate long-term. durable remissions, with 100% of treated Acute Myeloid Leukemia . patients remaining relapse-free with median follow-up of 20.1 months as. of January 17, 2025, as presented at the 2025 Transplantation & Cellular. -- On May 1st, 2025, we celebrated the 5th anniversary of the first patient. ever treated with a gamma-delta T cell therapy being developed by IN8bio.This older patient with complex AML and multiple genetic abnormalities. was treated with INB-100 and remains alive and in remission today. NEW YORK, May 07, 2025  -- IN8bio, Inc. , a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today reported financial results and business highlights for the first quarter ended March 31, 2025 and recent corporate highlights.Expanded Pipeline with INB-600 Gamma-Delta T Cell Engager Platform","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4006","BK4196","SBC","BK4211","BK4604","BK4097","BK4195","BK4099","BK4139","OS","BK4539","BK4585","INAB","IE0031619046.USD","PFS","IE00B7SZL793.SGD","LU2065731478.USD","IE00B19Z4B17.USD","TM","BK4588","BK4555","IE00B66KJ199.SGD","CRS"],"gpt_icon":0},{"id":"2531578034","title":"IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2531578034","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531578034?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:00","pubTimestamp":1745928000,"startTime":"0","endTime":"0","summary":"NEW YORK, April 29, 2025  -- IN8bio, Inc. , a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that it will present new clinical and preclinical data from its pipeline of gamma-delta T cell therapies at several upcoming scientific conferences.“The breadth of data we’re presenting at upcoming medical conferences reflects the scientific rigor and clinical potential of IN8bio’s gamma-delta T cell platform,” said William Ho, CEO and co-founder, IN8bio. “From our INB-200/400 program in newly glioblastoma to our novel T cell engager technologies, we are expanding the therapeutic applications of this unique class of therapies. These presentations highlight IN8bio’s capabilities, know-how in manufacturing, and the clinical potential of our programs to help patients with significant unmet needs across oncology and immune-mediated diseases.”Poster Presentation Title: INB-600: A Novel T Cell Engager Pla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/in8bio-present-clinical-preclinical-data-120000930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-06-06","symbol":"INAB","defaultRemindTime":1749216600000,"type":"split","dateTimestamp":1749182400000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-05-07","symbol":"INAB","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2021-09-10","symbol":"INAB","fiscalQuarterEnding":"2021/06","expectedEps":-0.3,"name":null,"time":"","type":"earning","dateTimestamp":1631246400000,"reportTimeType":"","actualEps":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1739332800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INAB","date":"2025-06-26","current":-0.27378,"percent":0.997124,"low":-60.555129,"twenty":-7.086741,"median":-1.822122,"eighty":-0.776294,"high":-0.267501,"avg":-7.836364,"sd":16.055539,"marketCap":7508421},"quantilePoints":[{"date":"2020-11-13","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-11-20","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-11-27","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-12-04","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-12-11","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-12-18","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-12-24","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2020-12-31","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-01-08","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-01-15","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-01-22","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-01-29","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-05","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-12","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-19","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-26","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-03-05","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-03-11","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-07-30","current":-20.321327,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":187545530},{"date":"2021-08-06","current":-19.792973,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":182669346},{"date":"2021-08-13","current":-19.000441,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":175355070},{"date":"2021-08-20","current":-15.667743,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":144597603},{"date":"2021-08-27","current":-14.936176,"twenty":-60.555129,"median":-60.555129,"eighty":-22.35346,"marketCap":137845964},{"date":"2021-09-03","current":-16.907344,"twenty":-60.555129,"median":-60.555129,"eighty":-20.215656,"marketCap":156037880},{"date":"2021-09-10","current":-17.727589,"twenty":-60.555129,"median":-60.555129,"eighty":-20.040893,"marketCap":166727976},{"date":"2021-09-17","current":-13.958732,"twenty":-60.555129,"median":-60.555129,"eighty":-19.085791,"marketCap":131281871},{"date":"2021-09-24","current":-15.155194,"twenty":-60.555129,"median":-60.555129,"eighty":-18.138817,"marketCap":142534602},{"date":"2021-10-01","current":-14.736432,"twenty":-60.555129,"median":-60.555129,"eighty":-17.663778,"marketCap":138596146},{"date":"2021-10-08","current":-12.881915,"twenty":-60.555129,"median":-60.555129,"eighty":-16.140999,"marketCap":121154412},{"date":"2021-10-15","current":-11.984369,"twenty":-60.555129,"median":-60.555129,"eighty":-15.651486,"marketCap":112712988},{"date":"2021-10-22","current":-13.280736,"twenty":-60.555129,"median":-60.555129,"eighty":-14.97998,"marketCap":124905322},{"date":"2021-10-29","current":-15.135253,"twenty":-60.555129,"median":-60.555129,"eighty":-14.672621,"marketCap":142347057},{"date":"2021-11-05","current":-14.955784,"twenty":-60.555129,"median":-60.555129,"eighty":-14.748397,"marketCap":140659147},{"date":"2021-11-12","current":-14.224101,"twenty":-60.555129,"median":-60.555129,"eighty":-14.60881,"marketCap":158100881},{"date":"2021-11-19","current":-11.473771,"twenty":-60.555129,"median":-22.35346,"eighty":-14.426892,"marketCap":127530960},{"date":"2021-11-26","current":-11.389405,"twenty":-60.555129,"median":-22.35346,"eighty":-13.958732,"marketCap":126593232},{"date":"2021-12-03","current":-9.448987,"twenty":-60.555129,"median":-20.321327,"eighty":-13.818503,"marketCap":105025496},{"date":"2021-12-10","current":-11.170053,"twenty":-60.555129,"median":-20.199399,"eighty":-13.58292,"marketCap":124155140},{"date":"2021-12-17","current":-10.36014,"twenty":-60.555129,"median":-20.04699,"eighty":-13.380441,"marketCap":115152955},{"date":"2021-12-23","current":-10.377013,"twenty":-60.555129,"median":-19.843776,"eighty":-13.252819,"marketCap":115340500},{"date":"2021-12-31","current":-7.407331,"twenty":-60.555129,"median":-19.000441,"eighty":-12.570834,"marketCap":82332487},{"date":"2022-01-07","current":-7.230163,"twenty":-60.555129,"median":-18.461926,"eighty":-12.206067,"marketCap":80363259},{"date":"2022-01-14","current":-6.833643,"twenty":-60.555129,"median":-17.887117,"eighty":-11.984528,"marketCap":75955939},{"date":"2022-01-21","current":-5.419838,"twenty":-60.555129,"median":-17.727589,"eighty":-11.677476,"marketCap":60241499},{"date":"2022-01-28","current":-5.061958,"twenty":-60.555129,"median":-16.898705,"eighty":-11.301664,"marketCap":56263659},{"date":"2022-02-04","current":-5.483787,"twenty":-60.555129,"median":-16.175776,"eighty":-10.967575,"marketCap":60952297},{"date":"2022-02-11","current":-7.069867,"twenty":-60.555129,"median":-15.983021,"eighty":-10.387137,"marketCap":78581577},{"date":"2022-02-18","current":-6.81677,"twenty":-60.555129,"median":-15.647422,"eighty":-10.120541,"marketCap":75768394},{"date":"2022-02-25","current":-7.322965,"twenty":-60.555129,"median":-15.411038,"eighty":-9.418616,"marketCap":81394760},{"date":"2022-03-04","current":-7.13736,"twenty":-60.555129,"median":-15.198094,"eighty":-9.287005,"marketCap":79331759},{"date":"2022-03-11","current":-5.399421,"twenty":-60.555129,"median":-15.055489,"eighty":-7.731297,"marketCap":60014569},{"date":"2022-03-18","current":-3.748845,"twenty":-60.555129,"median":-14.955784,"eighty":-7.444452,"marketCap":54931819},{"date":"2022-03-25","current":-4.288062,"twenty":-60.555129,"median":-14.796256,"eighty":-7.302717,"marketCap":62832971},{"date":"2022-04-01","current":-4.416447,"twenty":-60.555129,"median":-14.626756,"eighty":-7.171106,"marketCap":64714198},{"date":"2022-04-08","current":-5.289466,"twenty":-60.555129,"median":-14.428142,"eighty":-7.076617,"marketCap":77506540},{"date":"2022-04-14","current":-4.4687,"twenty":-60.555129,"median":-14.426579,"eighty":-6.951755,"marketCap":65479857},{"date":"2022-04-22","current":-4.64754,"twenty":-60.555129,"median":-14.038496,"eighty":-6.889324,"marketCap":68100406},{"date":"2022-04-29","current":-3.081242,"twenty":-60.555129,"median":-13.958732,"eighty":-6.820145,"marketCap":45149440},{"date":"2022-05-06","current":-3.346101,"twenty":-60.555129,"median":-13.77786,"eighty":-6.48268,"marketCap":49030411},{"date":"2022-05-13","current":-2.840843,"twenty":-60.555129,"median":-13.659616,"eighty":-6.014858,"marketCap":52370949},{"date":"2022-05-20","current":-2.237931,"twenty":-60.555129,"median":-13.521562,"eighty":-5.632272,"marketCap":41256251},{"date":"2022-05-27","current":-2.411651,"twenty":-60.555129,"median":-13.380441,"eighty":-5.517534,"marketCap":44458791},{"date":"2022-06-03","current":-2.707998,"twenty":-60.555129,"median":-13.280736,"eighty":-5.419838,"marketCap":49921948},{"date":"2022-06-10","current":-2.452527,"twenty":-60.555129,"median":-13.051414,"eighty":-5.315055,"marketCap":45212330},{"date":"2022-06-17","current":-2.3299,"twenty":-60.555129,"median":-12.582799,"eighty":-5.161081,"marketCap":42951713},{"date":"2022-06-24","current":-2.483183,"twenty":-60.555129,"median":-12.363448,"eighty":-4.711057,"marketCap":45777484},{"date":"2022-07-01","current":-2.268587,"twenty":-60.555129,"median":-12.190881,"eighty":-4.552535,"marketCap":41821405},{"date":"2022-07-08","current":-2.499738,"twenty":-60.555129,"median":-12.131058,"eighty":-4.42415,"marketCap":46082667},{"date":"2022-07-15","current":-2.217493,"twenty":-60.555129,"median":-11.984369,"eighty":-4.339416,"marketCap":40879482},{"date":"2022-07-22","current":-2.457636,"twenty":-60.555129,"median":-11.64557,"eighty":-4.254681,"marketCap":45306522},{"date":"2022-07-29","current":-2.595591,"twenty":-60.555129,"median":-11.473771,"eighty":-4.172515,"marketCap":47849716},{"date":"2022-08-05","current":-2.452527,"twenty":-60.555129,"median":-11.170053,"eighty":-3.923449,"marketCap":45212330},{"date":"2022-08-12","current":-1.544548,"twenty":-60.555129,"median":-11.035068,"eighty":-3.402872,"marketCap":34851171},{"date":"2022-08-19","current":-1.998049,"twenty":-60.555129,"median":-10.75666,"eighty":-3.158273,"marketCap":45083968},{"date":"2022-08-26","current":-2.128356,"twenty":-60.555129,"median":-10.377013,"eighty":-2.846974,"marketCap":48024227},{"date":"2022-09-02","current":-2.617009,"twenty":-60.555129,"median":-10.284211,"eighty":-2.79112,"marketCap":59050198},{"date":"2022-09-09","current":-2.682163,"twenty":-60.555129,"median":-9.879254,"eighty":-2.656101,"marketCap":60520327},{"date":"2022-09-16","current":-2.725599,"twenty":-60.555129,"median":-9.398368,"eighty":-2.67239,"marketCap":61500414},{"date":"2022-09-23","current":-2.160933,"twenty":-60.555129,"median":-9.330876,"eighty":-2.636466,"marketCap":48759292},{"date":"2022-09-30","current":-2.19351,"twenty":-60.555129,"median":-7.947273,"eighty":-2.595591,"marketCap":49494357},{"date":"2022-10-07","current":-2.258664,"twenty":-60.555129,"median":-7.736358,"eighty":-2.505541,"marketCap":50964486},{"date":"2022-10-14","current":-2.182651,"twenty":-60.555129,"median":-7.474824,"eighty":-2.483183,"marketCap":49249335},{"date":"2022-10-21","current":-1.607126,"twenty":-60.555129,"median":-7.415767,"eighty":-2.467985,"marketCap":36263192},{"date":"2022-10-28","current":-2.008908,"twenty":-60.555129,"median":-7.322965,"eighty":-2.452568,"marketCap":45328990},{"date":"2022-11-04","current":-1.954613,"twenty":-60.555129,"median":-7.225945,"eighty":-2.452527,"marketCap":44103882},{"date":"2022-11-11","current":-1.576798,"twenty":-45.274461,"median":-7.13736,"eighty":-2.40552,"marketCap":41898688},{"date":"2022-11-18","current":-1.318609,"twenty":-22.35346,"median":-7.086741,"eighty":-2.353137,"marketCap":35038084},{"date":"2022-11-25","current":-1.493809,"twenty":-22.35346,"median":-7.044557,"eighty":-2.336787,"marketCap":39693494},{"date":"2022-12-02","current":-1.954861,"twenty":-22.35346,"median":-6.951755,"eighty":-2.319682,"marketCap":51944572},{"date":"2022-12-09","current":-2.176166,"twenty":-21.947033,"median":-6.91379,"eighty":-2.291069,"marketCap":57825090},{"date":"2022-12-16","current":-1.576798,"twenty":-20.321327,"median":-6.867389,"eighty":-2.277598,"marketCap":41898688},{"date":"2022-12-23","current":-1.632125,"twenty":-20.30507,"median":-6.825207,"eighty":-2.25851,"marketCap":43368817},{"date":"2022-12-30","current":-2.130061,"twenty":-20.240042,"median":-6.79146,"eighty":-2.249935,"marketCap":56599982},{"date":"2023-01-06","current":-2.609555,"twenty":-20.207528,"median":-6.500397,"eighty":-2.249578,"marketCap":69341104},{"date":"2023-01-13","current":-2.130061,"twenty":-20.101857,"median":-6.293701,"eighty":-2.248149,"marketCap":56599982},{"date":"2023-01-20","current":-2.139282,"twenty":-20.065278,"median":-6.008422,"eighty":-2.222649,"marketCap":56845004},{"date":"2023-01-27","current":-2.102398,"twenty":-20.044957,"median":-5.763894,"eighty":-2.196076,"marketCap":55864917},{"date":"2023-02-03","current":-2.231493,"twenty":-19.951479,"median":-5.568153,"eighty":-2.194169,"marketCap":59295219},{"date":"2023-02-10","current":-1.779661,"twenty":-19.833615,"median":-5.517534,"eighty":-2.176617,"marketCap":47289163},{"date":"2023-02-17","current":-1.800593,"twenty":-19.573503,"median":-5.483787,"eighty":-2.16454,"marketCap":47845361},{"date":"2023-02-24","current":-1.346272,"twenty":-19.25649,"median":-5.405012,"eighty":-2.156798,"marketCap":35773149},{"date":"2023-03-03","current":-1.456925,"twenty":-18.976055,"median":-5.348802,"eighty":-2.139282,"marketCap":38713408},{"date":"2023-03-10","current":-1.171073,"twenty":-18.760649,"median":-5.247563,"eighty":-2.137131,"marketCap":31117739},{"date":"2023-03-17","current":-1.078862,"twenty":-18.468022,"median":-5.111519,"eighty":-2.129038,"marketCap":28667523},{"date":"2023-03-24","current":-1.134188,"twenty":-18.28513,"median":-4.724571,"eighty":-2.11729,"marketCap":30137653},{"date":"2023-03-31","current":-1.116819,"twenty":-17.994243,"median":-4.628283,"eighty":-2.093853,"marketCap":31852804},{"date":"2023-04-06","current":-1.013728,"twenty":-17.857797,"median":-4.525575,"eighty":-2.054716,"marketCap":28912545},{"date":"2023-04-14","current":-1.108228,"twenty":-17.737933,"median":-4.429286,"eighty":-2.044514,"marketCap":31607782},{"date":"2023-04-21","current":-0.9793,"twenty":-17.711636,"median":-4.39077,"eighty":-2.024631,"marketCap":27930624},{"date":"2023-04-28","current":-1.600107,"twenty":-17.499729,"median":-4.3009,"eighty":-2.010187,"marketCap":45636646},{"date":"2023-05-05","current":-2.002319,"twenty":-16.903888,"median":-4.281643,"eighty":-2.008908,"marketCap":57108152},{"date":"2023-05-12","current":-1.906138,"twenty":-16.800043,"median":-4.223869,"eighty":-2.008908,"marketCap":54364966},{"date":"2023-05-19","current":-3.134129,"twenty":-16.387118,"median":-4.172515,"eighty":-2.008908,"marketCap":93713596},{"date":"2023-05-26","current":-2.576951,"twenty":-16.167082,"median":-4.031292,"eighty":-2.009164,"marketCap":77053401},{"date":"2023-06-02","current":-3.044583,"twenty":-16.132305,"median":-3.87723,"eighty":-2.010187,"marketCap":91036064},{"date":"2023-06-09","current":-2.397858,"twenty":-16.013206,"median":-3.466397,"eighty":-2.010187,"marketCap":71698338},{"date":"2023-06-16","current":-2.109319,"twenty":-15.952836,"median":-3.338012,"eighty":-2.010187,"marketCap":63070737},{"date":"2023-06-23","current":-1.910326,"twenty":-15.724762,"median":-3.218941,"eighty":-2.008908,"marketCap":57120668},{"date":"2023-06-30","current":-1.611838,"twenty":-15.65555,"median":-3.138239,"eighty":-2.001778,"marketCap":48195563},{"date":"2023-07-07","current":-1.661586,"twenty":-15.570177,"median":-3.134129,"eighty":-1.998049,"marketCap":49683081},{"date":"2023-07-14","current":-1.691435,"twenty":-15.437001,"median":-3.034633,"eighty":-1.966279,"marketCap":50575591},{"date":"2023-07-21","current":-1.591939,"twenty":-15.343021,"median":-2.997073,"eighty":-1.948098,"marketCap":47600556},{"date":"2023-07-28","current":-1.238727,"twenty":-15.240995,"median":-2.910292,"eighty":-1.927198,"marketCap":37039183},{"date":"2023-08-04","current":-1.263601,"twenty":-15.206675,"median":-2.86549,"eighty":-1.903019,"marketCap":37782941},{"date":"2023-08-11","current":-1.144206,"twenty":-15.147218,"median":-2.826657,"eighty":-1.879294,"marketCap":34212900},{"date":"2023-08-18","current":-1.183602,"twenty":-15.103347,"median":-2.765993,"eighty":-1.844935,"marketCap":36025305},{"date":"2023-08-25","current":-1.059013,"twenty":-15.015607,"median":-2.720922,"eighty":-1.788034,"marketCap":32233167},{"date":"2023-09-01","current":-1.09016,"twenty":-14.955784,"median":-2.706296,"eighty":-1.751998,"marketCap":33181202},{"date":"2023-09-08","current":-1.005128,"twenty":-14.955784,"median":-2.665875,"eighty":-1.734645,"marketCap":30593068},{"date":"2023-09-15","current":-0.975953,"twenty":-14.951862,"median":-2.637688,"eighty":-1.702114,"marketCap":29705076},{"date":"2023-09-22","current":-1.204367,"twenty":-14.908192,"median":-2.636466,"eighty":-1.688248,"marketCap":36657328},{"date":"2023-09-29","current":-1.152455,"twenty":-14.784291,"median":-2.613282,"eighty":-1.672875,"marketCap":35077270},{"date":"2023-10-06","current":-1.017587,"twenty":-14.720479,"median":-2.595591,"eighty":-1.660148,"marketCap":30972282},{"date":"2023-10-13","current":-0.986335,"twenty":-14.644703,"median":-2.581926,"eighty":-1.631815,"marketCap":30021087},{"date":"2023-10-20","current":-0.996718,"twenty":-14.592857,"median":-2.545008,"eighty":-1.604995,"marketCap":30337099},{"date":"2023-10-27","current":-1.038248,"twenty":-14.58488,"median":-2.535787,"eighty":-1.598161,"marketCap":31601145},{"date":"2023-11-03","current":-1.038248,"twenty":-14.487647,"median":-2.512992,"eighty":-1.579913,"marketCap":31601145},{"date":"2023-11-10","current":-1.04863,"twenty":-14.428142,"median":-2.508124,"eighty":-1.53388,"marketCap":31917156},{"date":"2023-11-17","current":-0.975284,"twenty":-14.427204,"median":-2.499738,"eighty":-1.499342,"marketCap":29460407},{"date":"2023-11-24","current":-0.773116,"twenty":-14.345588,"median":-2.483183,"eighty":-1.472685,"marketCap":23353524},{"date":"2023-12-01","current":-0.879023,"twenty":-14.181765,"median":-2.475843,"eighty":-1.42357,"marketCap":26552637},{"date":"2023-12-08","current":-1.045507,"twenty":-14.054449,"median":-2.460191,"eighty":-1.396066,"marketCap":31581643},{"date":"2023-12-15","current":-2.478208,"twenty":-13.958732,"median":-2.457636,"eighty":-1.392378,"marketCap":74859244},{"date":"2023-12-22","current":-1.846609,"twenty":-13.958732,"median":-2.452578,"eighty":-1.396066,"marketCap":55780526},{"date":"2023-12-29","current":-2.032702,"twenty":-13.958732,"median":-2.452527,"eighty":-1.401599,"marketCap":61401819},{"date":"2024-01-05","current":-1.989757,"twenty":-13.925599,"median":-2.452527,"eighty":-1.402377,"marketCap":60104598},{"date":"2024-01-12","current":-2.204479,"twenty":-13.852506,"median":-2.432089,"eighty":-1.40765,"marketCap":66590705},{"date":"2024-01-19","current":-2.063553,"twenty":-13.785989,"median":-2.419201,"eighty":-1.41082,"marketCap":62333748},{"date":"2024-01-26","current":-1.86293,"twenty":-13.736241,"median":-2.404062,"eighty":-1.42357,"marketCap":56273522},{"date":"2024-02-02","current":-1.719628,"twenty":-13.704713,"median":-2.380995,"eighty":-1.448386,"marketCap":51944790},{"date":"2024-02-09","current":-1.748288,"twenty":-13.628938,"median":-2.367158,"eighty":-1.456925,"marketCap":52810536},{"date":"2024-02-16","current":-1.576325,"twenty":-13.58292,"median":-2.350965,"eighty":-1.460613,"marketCap":47616057},{"date":"2024-02-23","current":-1.447353,"twenty":-13.558377,"median":-2.345229,"eighty":-1.458769,"marketCap":43720198},{"date":"2024-03-01","current":-1.590655,"twenty":-13.444252,"median":-2.3299,"eighty":-1.456925,"marketCap":48048930},{"date":"2024-03-08","current":-1.748288,"twenty":-13.380441,"median":-2.319682,"eighty":-1.458769,"marketCap":52810536},{"date":"2024-03-15","current":-1.662307,"twenty":-13.376453,"median":-2.304353,"eighty":-1.46812,"marketCap":50213297},{"date":"2024-03-22","current":-1.803218,"twenty":-13.344547,"median":-2.289025,"eighty":-1.47731,"marketCap":54109156},{"date":"2024-03-28","current":-1.745515,"twenty":-13.280736,"median":-2.278806,"eighty":-1.482493,"marketCap":52377663},{"date":"2024-04-05","current":-1.615683,"twenty":-13.260795,"median":-2.273092,"eighty":-1.493809,"marketCap":48481804},{"date":"2024-04-12","current":-1.65896,"twenty":-13.220913,"median":-2.258664,"eighty":-1.493809,"marketCap":49780423},{"date":"2024-04-19","current":-1.514703,"twenty":-12.881915,"median":-2.256631,"eighty":-1.482493,"marketCap":45451691},{"date":"2024-04-26","current":-1.500277,"twenty":-12.662564,"median":-2.248149,"eighty":-1.482493,"marketCap":45018818},{"date":"2024-05-03","current":-1.496325,"twenty":-12.582799,"median":-2.24304,"eighty":-1.482493,"marketCap":44900232},{"date":"2024-05-10","current":-1.432162,"twenty":-12.522976,"median":-2.231493,"eighty":-1.471426,"marketCap":44460034},{"date":"2024-05-17","current":-1.446342,"twenty":-12.363448,"median":-2.22179,"eighty":-1.466146,"marketCap":44900232},{"date":"2024-05-24","current":-1.47456,"twenty":-12.249186,"median":-2.21305,"eighty":-1.460522,"marketCap":45776227},{"date":"2024-05-31","current":-1.463976,"twenty":-12.22279,"median":-2.204479,"eighty":-1.456925,"marketCap":45447667},{"date":"2024-06-07","current":-1.606109,"twenty":-12.175695,"median":-2.195832,"eighty":-1.459803,"marketCap":49860062},{"date":"2024-06-14","current":-2.387844,"twenty":-12.164651,"median":-2.194059,"eighty":-1.462594,"marketCap":74128234},{"date":"2024-06-21","current":-1.307913,"twenty":-12.137654,"median":-2.185365,"eighty":-1.456925,"marketCap":40602857},{"date":"2024-06-28","current":-1.278207,"twenty":-12.111271,"median":-2.180423,"eighty":-1.456032,"marketCap":39680667},{"date":"2024-07-05","current":-1.134937,"twenty":-12.029972,"median":-2.177406,"eighty":-1.446342,"marketCap":35232973},{"date":"2024-07-12","current":-1.194064,"twenty":-11.984449,"median":-2.176166,"eighty":-1.442646,"marketCap":37068529},{"date":"2024-07-15","current":-1.247649,"twenty":-11.984409,"median":-2.173979,"eighty":-1.442545,"marketCap":38732002},{"date":"2024-08-02","current":-1.208135,"twenty":-11.984369,"median":-2.171792,"eighty":-1.44243,"marketCap":37505356},{"date":"2024-08-09","current":-0.972336,"twenty":-11.964627,"median":-2.163939,"eighty":-1.432162,"marketCap":30185193},{"date":"2024-08-16","current":-0.882654,"twenty":-11.805099,"median":-2.157724,"eighty":-1.410954,"marketCap":28207850},{"date":"2024-08-23","current":-0.761433,"twenty":-11.486042,"median":-2.153127,"eighty":-1.401599,"marketCap":24333891},{"date":"2024-08-30","current":-0.760116,"twenty":-11.473771,"median":-2.145961,"eighty":-1.383157,"marketCap":24291783},{"date":"2024-09-06","current":-0.49469,"twenty":-11.473771,"median":-2.139282,"eighty":-1.363657,"marketCap":15809309},{"date":"2024-09-13","current":-0.440961,"twenty":-11.406278,"median":-2.139215,"eighty":-1.340739,"marketCap":14092228},{"date":"2024-09-20","current":-0.470095,"twenty":-11.213923,"median":-2.135742,"eighty":-1.289457,"marketCap":15023289},{"date":"2024-09-27","current":-0.417244,"twenty":-11.170053,"median":-2.130061,"eighty":-1.276954,"marketCap":13334280},{"date":"2024-10-04","current":-0.3865,"twenty":-11.143056,"median":-2.126474,"eighty":-1.252451,"marketCap":12351754},{"date":"2024-10-11","current":-0.336577,"twenty":-11.055316,"median":-2.117497,"eighty":-1.235515,"marketCap":10756319},{"date":"2024-10-18","current":-0.33687,"twenty":-10.900082,"median":-2.109319,"eighty":-1.21758,"marketCap":10765676},{"date":"2024-10-25","current":-0.468631,"twenty":-10.812342,"median":-2.095323,"eighty":-1.203755,"marketCap":14976502},{"date":"2024-10-31","current":-0.39543,"twenty":-10.748223,"median":-2.092695,"eighty":-1.194032,"marketCap":12637154},{"date":"2024-11-08","current":-0.484003,"twenty":-10.522122,"median":-2.089364,"eighty":-1.182279,"marketCap":15467765},{"date":"2024-11-15","current":-0.493189,"twenty":-10.383762,"median":-2.069928,"eighty":-1.172361,"marketCap":15720414},{"date":"2024-11-22","current":-0.727675,"twenty":-10.366889,"median":-2.063526,"eighty":-1.163203,"marketCap":23194640},{"date":"2024-11-29","current":-0.692883,"twenty":-10.333143,"median":-2.052343,"eighty":-1.153748,"marketCap":22085647},{"date":"2024-12-06","current":-0.682195,"twenty":-10.285898,"median":-2.047072,"eighty":-1.146883,"marketCap":21744975},{"date":"2024-12-13","current":-0.66082,"twenty":-10.120541,"median":-2.043874,"eighty":-1.13907,"marketCap":21063633},{"date":"2024-12-20","current":-0.546666,"twenty":-9.880941,"median":-2.034998,"eighty":-1.134188,"marketCap":17424974},{"date":"2024-12-27","current":-0.578502,"twenty":-9.786451,"median":-2.03022,"eighty":-1.134038,"marketCap":18439739},{"date":"2025-01-03","current":-0.63717,"twenty":-9.448987,"median":-2.021551,"eighty":-1.122855,"marketCap":20309807},{"date":"2025-01-10","current":-0.710847,"twenty":-9.408492,"median":-2.010187,"eighty":-1.116819,"marketCap":22658264},{"date":"2025-01-17","current":-0.674464,"twenty":-9.371371,"median":-2.008908,"eighty":-1.107887,"marketCap":21498532},{"date":"2025-01-24","current":-0.652179,"twenty":-9.364622,"median":-2.004072,"eighty":-1.101073,"marketCap":20788196},{"date":"2025-01-31","current":-0.563721,"twenty":-9.324126,"median":-2.001642,"eighty":-1.097961,"marketCap":17968598},{"date":"2025-02-07","current":-0.629894,"twenty":-9.287005,"median":-1.998049,"eighty":-1.084711,"marketCap":20077861},{"date":"2025-02-14","current":-0.734724,"twenty":-8.480466,"median":-1.989757,"eighty":-1.079412,"marketCap":23419339},{"date":"2025-02-21","current":-0.65036,"twenty":-7.873031,"median":-1.984857,"eighty":-1.069395,"marketCap":20730210},{"date":"2025-02-28","current":-0.576228,"twenty":-7.761668,"median":-1.963783,"eighty":-1.052376,"marketCap":18367256},{"date":"2025-03-07","current":-0.58828,"twenty":-7.74142,"median":-1.954613,"eighty":-1.046541,"marketCap":18751417},{"date":"2025-03-14","current":-0.514603,"twenty":-7.684052,"median":-1.94723,"eighty":-1.038248,"marketCap":16402960},{"date":"2025-03-21","current":-0.621782,"twenty":-7.576063,"median":-1.937378,"eighty":-1.029162,"marketCap":18925165},{"date":"2025-03-28","current":-0.555572,"twenty":-7.474824,"median":-1.932498,"eighty":-1.018376,"marketCap":16909948},{"date":"2025-04-04","current":-0.430361,"twenty":-7.454576,"median":-1.923725,"eighty":-1.015188,"marketCap":13098912},{"date":"2025-04-11","current":-0.392718,"twenty":-7.417455,"median":-1.910326,"eighty":-1.00529,"marketCap":11953164},{"date":"2025-04-17","current":-0.42075,"twenty":-7.400582,"median":-1.906138,"eighty":-0.992946,"marketCap":12806381},{"date":"2025-04-25","current":-0.493901,"twenty":-7.363461,"median":-1.902764,"eighty":-0.983856,"marketCap":15032871},{"date":"2025-05-02","current":-0.453588,"twenty":-7.316216,"median":-1.899535,"eighty":-0.976534,"marketCap":13805863},{"date":"2025-05-09","current":-0.497478,"twenty":-7.277408,"median":-1.883407,"eighty":-0.972926,"marketCap":13643346},{"date":"2025-05-16","current":-0.438552,"twenty":-7.228476,"median":-1.871872,"eighty":-0.963991,"marketCap":12027282},{"date":"2025-05-23","current":-0.439545,"twenty":-7.221726,"median":-1.86293,"eighty":-0.937651,"marketCap":12054514},{"date":"2025-05-30","current":-0.507727,"twenty":-7.221726,"median":-1.86244,"eighty":-0.918094,"marketCap":13924416},{"date":"2025-06-06","current":-0.452491,"twenty":-7.13736,"median":-1.85343,"eighty":-0.881988,"marketCap":12409571},{"date":"2025-06-13","current":-0.298898,"twenty":-7.120487,"median":-1.846259,"eighty":-0.836826,"marketCap":8197267},{"date":"2025-06-20","current":-0.267501,"twenty":-7.09349,"median":-1.844209,"eighty":-0.789983,"marketCap":7336209},{"date":"2025-06-26","current":-0.27378,"twenty":-7.086741,"median":-1.822122,"eighty":-0.776294,"marketCap":7508421}],"updateTime":1751022839656}}}